» Articles » PMID: 14751761

Toll-like Receptors and Dendritic Cells: for Whom the Bug Tolls

Overview
Journal Semin Immunol
Date 2004 Jan 31
PMID 14751761
Citations 106
Authors
Affiliations
Soon will be listed here.
Abstract

Recognition of molecular signatures of potential pathogens via toll-like receptors (TLRs) activates dendritic cells (DC), leading to the initiation of adaptive immunity. TLR signalling in DC causes an increase in display of MHC peptide ligands for T cell recognition, upregulation of co-stimulatory molecules important for T cell clonal expansion and secretion of immunomodulatory cytokines, which direct T cell differentiation into effectors. Remarkably, ligation of distinct TLRs can trigger differential cytokine production in a single DC type or result in different cytokines in distinct DC sub-types. Studying the complexity of DC responses to TLR ligands illuminates the link between innate recognition and adaptive immunity, paving the way for improved vaccines and strategies to induce tolerance to autoantigens or allografts.

Citing Articles

Targeting of Non-Classical Human Leukocyte Antigens as Novel Therapeutic Strategies in Cancer.

Benitez Fuentes J, Bartolome Arcilla J, Mohamed Mohamed K, Lopez de Sa A, de Luna Aguilar A, Guevara-Hoyer K Cancers (Basel). 2025; 16(24.

PMID: 39766165 PMC: 11675049. DOI: 10.3390/cancers16244266.


The Modification of H3K4me3 Enhanced the Expression of TLR3 in Hemocytes to Increase IL17-1 Production in the Immune Priming of .

Lian X, Li Y, Wang W, Zuo J, Yu T, Wang L Int J Mol Sci. 2024; 25(2).

PMID: 38256110 PMC: 10816183. DOI: 10.3390/ijms25021036.


Cell-targeted vaccines: implications for adaptive immunity.

Ung T, Rutledge N, Weiss A, Esser-Kahn A, Deak P Front Immunol. 2023; 14:1221008.

PMID: 37662903 PMC: 10468591. DOI: 10.3389/fimmu.2023.1221008.


Advancements in Marburg (MARV) Virus Vaccine Research With Its Recent Reemergence in Equatorial Guinea and Tanzania: A Scoping Review.

Mane Manohar M, Lee V, Chinedum Odunukwe E, Singh P, Mpofu B, Oxley Md C Cureus. 2023; 15(7):e42014.

PMID: 37593293 PMC: 10430785. DOI: 10.7759/cureus.42014.


Immunopotentiating Activity of Fucoidans and Relevance to Cancer Immunotherapy.

Li Y, McGowan E, Chen S, Santos J, Yin H, Lin Y Mar Drugs. 2023; 21(2).

PMID: 36827169 PMC: 9961398. DOI: 10.3390/md21020128.